Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the safety, reactogenicity and immunogenicity of EV71 vaccine in health children and infants aged from 2 months to <12yrs.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02200237
Study type Interventional
Source Medigen Vaccine Biologics Corp.
Contact
Status Completed
Phase Phase 2
Start date September 2014
Completion date August 2017

See also
  Status Clinical Trial Phase
Completed NCT04072276 - Long-Term Immunogenicity Study of Inactivated EV71 Vaccine in Children